213 related articles for article (PubMed ID: 31692151)
41. Polypharmacy, the Elderly, and Deprescribing.
Jetha S
Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review.
Cardona M; Stehlik P; Fawzy P; Byambasuren O; Anderson J; Clark J; Sun S; Scott I
Expert Opin Drug Saf; 2021 Jan; 20(1):81-91. PubMed ID: 33213216
[No Abstract] [Full Text] [Related]
43. Prescribing patterns of polypharmacy in Korean pediatric patients.
Jeon SM; Park S; Rhie SJ; Kwon JW
PLoS One; 2019; 14(10):e0222781. PubMed ID: 31574095
[TBL] [Abstract][Full Text] [Related]
44. [Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study in Dutch community pharmacies].
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Ned Tijdschr Geneeskd; 2016; 160():D439. PubMed ID: 27924735
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of drug-related problems in older polypharmacy primary care patients.
Kovačević SV; Miljković B; Ćulafić M; Kovačević M; Golubović B; Jovanović M; Vučićević K; de Gier JJ
J Eval Clin Pract; 2017 Aug; 23(4):860-865. PubMed ID: 28370742
[TBL] [Abstract][Full Text] [Related]
46. Variations in drug-related problems detected by multidisciplinary teams in Norwegian nursing homes and home nursing care.
Devik SA; Olsen RM; Fiskvik IL; Halbostad T; Lassen T; Kuzina N; Enmarker I
Scand J Prim Health Care; 2018 Sep; 36(3):291-299. PubMed ID: 30139278
[TBL] [Abstract][Full Text] [Related]
47. Physicians need to take the lead in deprescribing.
Scott IA; Le Couteur DG
Intern Med J; 2015 Mar; 45(3):352-6. PubMed ID: 25735580
[TBL] [Abstract][Full Text] [Related]
48. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
Todd A; Jansen J; Colvin J; McLachlan AJ
BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
[TBL] [Abstract][Full Text] [Related]
49. The effectiveness of optimised clinical medication reviews for geriatric patients: Opti-Med a cluster randomised controlled trial.
Willeboordse F; Schellevis FG; Chau SH; Hugtenburg JG; Elders PJM
Fam Pract; 2017 Aug; 34(4):437-445. PubMed ID: 28334979
[TBL] [Abstract][Full Text] [Related]
50. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
Simões PA; Santiago LM; Simões JA
BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
[TBL] [Abstract][Full Text] [Related]
51. Cross-sectional investigation of drug-related problems among adults in a medical center outpatient clinic: application of virtual medicine records in the cloud.
Wang HY; Yeh MK; Ho CH; Hu MK; Huang YB
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):71-80. PubMed ID: 27730699
[TBL] [Abstract][Full Text] [Related]
52. Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus.
Tan ECK; Sluggett JK; Johnell K; Onder G; Elseviers M; Morin L; Vetrano DL; Wastesson JW; Fastbom J; Taipale H; Tanskanen A; Bell JS;
J Am Med Dir Assoc; 2018 Mar; 19(3):193-199. PubMed ID: 29361432
[TBL] [Abstract][Full Text] [Related]
53. Outcome Measures for Interventions to Reduce Inappropriate Chronic Drugs: A Narrative Review.
Aubert CE; Kerr EA; Maratt JK; Klamerus ML; Hofer TP
J Am Geriatr Soc; 2020 Oct; 68(10):2390-2398. PubMed ID: 32780416
[TBL] [Abstract][Full Text] [Related]
54. Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria.
Verdoorn S; Kwint HF; Faber A; Gussekloo J; Bouvy ML
Eur J Clin Pharmacol; 2015 Oct; 71(10):1255-62. PubMed ID: 26249851
[TBL] [Abstract][Full Text] [Related]
55. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.
Page AT; Clifford RM; Potter K; Schwartz D; Etherton-Beer CD
Br J Clin Pharmacol; 2016 Sep; 82(3):583-623. PubMed ID: 27077231
[TBL] [Abstract][Full Text] [Related]
56. Less Really Is More in Inappropriate Medication Use in Older Adults: How Can We Improve Prescribing and Deprescribing in Older Adults?
Fick DM
J Am Geriatr Soc; 2020 Jun; 68(6):1175-1176. PubMed ID: 32364621
[No Abstract] [Full Text] [Related]
57. Polypharmacy and deprescribing: just ask the patient.
Cave JA
Drug Ther Bull; 2020 Jan; 58(1):2. PubMed ID: 31727779
[No Abstract] [Full Text] [Related]
58. [List-based concepts in pharmacotherapy of older and geriatric patients].
Thiem U
Z Gerontol Geriatr; 2018 Jun; 51(4):394-398. PubMed ID: 29725752
[TBL] [Abstract][Full Text] [Related]
59. Factors influencing deprescribing habits among geriatricians.
Ní Chróinín D; Ní Chróinín C; Beveridge A
Age Ageing; 2015 Jul; 44(4):704-8. PubMed ID: 25758409
[TBL] [Abstract][Full Text] [Related]
60. Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers.
Ramsdale E; Lemelman T; Loh KP; Flannery M; Kehoe L; Mullaney T; Wells M; Gilmore N; Plumb S; Mohile S
J Geriatr Oncol; 2018 Sep; 9(5):534-539. PubMed ID: 29530495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
